Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Marc Helberg

Advertisement

Managing Vice President at the Philadelphia Office of Pariveda

Articles by Marc Helberg

What the COVID-19 Vaccine Process Showed Us, and How It Can Impact the Future of Drug Development

ByMarc Helberg
May 10th 2022

Industry has shown it can overcome challenges en route to creating new therapies.

Advertisement

Latest Updated Articles

  • What the COVID-19 Vaccine Process Showed Us, and How It Can Impact the Future of Drug Development
    What the COVID-19 Vaccine Process Showed Us, and How It Can Impact the Future of Drug Development

    May 10th 2022



Advertisement
Advertisement

Trending on PharmExec

1

The Industry’s Communication and Engagement with FDA

2

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

3

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

4

Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio

5

The Evolving Relationship Between FDA and Biotech

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us